These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11295704)
21. beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes. Eichhorn EJ; Grayburn PA Am Heart J; 2000 Apr; 139(4):584-6. PubMed ID: 10740138 [No Abstract] [Full Text] [Related]
26. Carvedilol therapy in heart failure--III. Lee YC J Am Coll Cardiol; 1995 Nov; 26(5):1400-1. PubMed ID: 7594061 [No Abstract] [Full Text] [Related]
27. Major heart failure news from 2001. Francis D Heart Fail Monit; 2002; 2(4):147-8. PubMed ID: 12638556 [No Abstract] [Full Text] [Related]
28. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. Lindenfeld J; Lowes BD; Bristow MR Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826 [TBL] [Abstract][Full Text] [Related]
29. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world? Wollert KC; Drexler H Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940 [No Abstract] [Full Text] [Related]
30. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure. Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865 [TBL] [Abstract][Full Text] [Related]
31. Carvedilol therapy in heart failure--II. Carbajal EV J Am Coll Cardiol; 1995 Nov; 26(5):1399-400; author reply 1400-1. PubMed ID: 7594060 [No Abstract] [Full Text] [Related]
32. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Packer M; Fowler MB; Roecker EB; Coats AJ; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Staiger C; Holcslaw TL; Amann-Zalan I; DeMets DL; Circulation; 2002 Oct; 106(17):2194-9. PubMed ID: 12390947 [TBL] [Abstract][Full Text] [Related]
33. Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report. Acharya NV; Wilton LV; Shakir SA Int J Clin Pharmacol Ther; 2005 Jan; 43(1):1-6. PubMed ID: 15704607 [TBL] [Abstract][Full Text] [Related]
34. Carvedilol therapy in heart failure--I. Ghali JK J Am Coll Cardiol; 1995 Nov; 26(5):1399; author reply 1400-1. PubMed ID: 7594059 [No Abstract] [Full Text] [Related]
35. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419 [TBL] [Abstract][Full Text] [Related]
37. COMET: a proposed mechanism of action to explain the results and concerns about dose. Coca SG; Buller GK Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541 [No Abstract] [Full Text] [Related]
38. Carvedilol in class IV heart failure. Hoffman I J Am Coll Cardiol; 1999 Dec; 34(7):2149-50. PubMed ID: 10588239 [No Abstract] [Full Text] [Related]